Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs ELDER PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH ELDER PHARMA WYETH/
ELDER PHARMA
 
P/E (TTM) x 27.7 -1.0 - View Chart
P/BV x 11.3 0.1 11,158.3% View Chart
Dividend Yield % 10.9 0.0 -  

Financials

 WYETH   ELDER PHARMA
EQUITY SHARE DATA
    WYETH
Mar-14
ELDER PHARMA
Jun-14
WYETH/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs1,065380 280.3%   
Low Rs553188 294.2%   
Sales per share (Unadj.) Rs289.5489.2 59.2%  
Earnings per share (Unadj.) Rs38.7-3.2 -1,217.0%  
Cash flow per share (Unadj.) Rs39.914.4 276.9%  
Dividends per share (Unadj.) Rs145.000-  
Avg Dividend yield %17.90-  
Book value per share (Unadj.) Rs118.5376.5 31.5%  
Shares outstanding (eoy) m22.7220.54 110.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.80.6 481.5%   
Avg P/E ratio x20.9-89.3 -23.4%  
P/CF ratio (eoy) x20.319.7 102.9%  
Price / Book Value ratio x6.80.8 905.1%  
Dividend payout %374.70-   
Avg Mkt Cap Rs m18,3815,832 315.2%   
No. of employees `000NANA-   
Total wages/salary Rs m3592,179 16.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,57710,048 65.5%  
Other income Rs m347257 135.4%   
Total revenues Rs m6,92510,305 67.2%   
Gross profit Rs m1,0232,921 35.0%  
Depreciation Rs m27361 7.6%   
Interest Rs m42,756 0.2%   
Profit before tax Rs m1,33960 2,237.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m460125 367.2%   
Profit after tax Rs m879-65 -1,346.2%  
Gross profit margin %15.629.1 53.5%  
Effective tax rate %34.3209.1 16.4%   
Net profit margin %13.4-0.6 -2,056.6%  
BALANCE SHEET DATA
Current assets Rs m3,9649,240 42.9%   
Current liabilities Rs m2,0819,998 20.8%   
Net working cap to sales %28.6-7.5 -379.6%  
Current ratio x1.90.9 206.1%  
Inventory Days Days35128 27.4%  
Debtors Days Days278602 46.1%  
Net fixed assets Rs m87813,642 6.4%   
Share capital Rs m227206 110.5%   
"Free" reserves Rs m2,4667,528 32.8%   
Net worth Rs m2,6937,733 34.8%   
Long term debt Rs m254,889 0.5%   
Total assets Rs m4,84222,882 21.2%  
Interest coverage x306.01.0 29,946.7%   
Debt to equity ratio x00.6 1.5%  
Sales to assets ratio x1.40.4 309.3%   
Return on assets %18.211.8 155.2%  
Return on equity %32.6-0.8 -3,866.1%  
Return on capital %49.422.3 221.5%  
Exports to sales %0.13.1 3.8%   
Imports to sales %34.70.4 8,084.8%   
Exports (fob) Rs m8307 2.5%   
Imports (cif) Rs m2,28143 5,292.5%   
Fx inflow Rs m8307 2.5%   
Fx outflow Rs m2,298125 1,834.7%   
Net fx Rs m-2,291181 -1,263.3%   
CASH FLOW
From Operations Rs m1,18811,754 10.1%  
From Investments Rs m287-561 -51.2%  
From Financial Activity Rs m-4,296-6,762 63.5%  
Net Cashflow Rs m-2,8215,466 -51.6%  

Share Holding

Indian Promoters % 0.0 25.3 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 18.4 24.0 76.6%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.9 74.7 65.5%  
Shareholders   25,706 31,548 81.5%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on WYETH vs Elder Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

WYETH vs Elder Pharma Share Price Performance

Period WYETH Elder Pharma S&P BSE HEALTHCARE
1-Day -2.27% 4.97% 1.39%
1-Month 18.58% 21.21% -0.54%
1-Year 69.59% -64.54% 62.16%
3-Year CAGR 15.36% -51.65% 18.24%
5-Year CAGR 8.95% -37.46% 19.84%

* Compound Annual Growth Rate

Here are more details on the WYETH share price and the Elder Pharma share price.

Moving on to shareholding structures...

The promoters of WYETH hold a 51.1% stake in the company. In case of Elder Pharma the stake stands at 25.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WYETH and the shareholding pattern of Elder Pharma.

Finally, a word on dividends...

In the most recent financial year, WYETH paid a dividend of Rs 145.0 per share. This amounted to a Dividend Payout ratio of 374.7%.

Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of WYETH, and the dividend history of Elder Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.